Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 308

Meilishuo makes plans for US IPO

The Tencent and Bertelsmann-backed social commerce platform has spoken to potential advisors and underwriters about an offering that could value it at $4bn.

Apr 16, 2018

6sense roots out ZenIQ

Salesforce Ventures has exited ZenIQ through an acquisition by 6Sense, after co-leading a $4.6m round for the company last year.

Apr 13, 2018

Ant Financial anticipates $150bn valuation in latest round

Alibaba's financial services affiliate has reportedly already raised $3bn from investors including Temasek and is targeting an $8bn to $9bn close.

Apr 11, 2018

C-Sats records acquisition

Johnson & Johnson has bought UW spinout C-Sats, which has created a platform to evaluate surgeons and helps them boost their skills.

Apr 11, 2018

Inspire Medical to make inroads on public markets

Medtronic spinout Inspire Medical Systems, the developer of a neurostimulation device for sleep apnea, has targeted $86.3m for its IPO.

Apr 10, 2018

Pivotal pinpoints $530m target for IPO

The Dell EMC spinout has set the range for an offering in which General Electric will sell up to $62m of shares.

Apr 10, 2018

Huya targets $200m as it joins IPO stream

The YY-founded live game streaming platform raised $462m from Tencent last month at a valuation of $1.16bn.

Apr 10, 2018

Unity Biotechnology gets to IPO age with $85m filing

The age-related disease drug developer, which counts Mayo Clinic and WuXi PharmaTech as investors, raised $55m as recently as last month.

Apr 9, 2018

UCB defines Element Genomics acquisition

Duke spinout Element could generate as much as $30m from the sale, which will enable UCB to boost its research capabilities.

Apr 5, 2018

Ola solves Ridlr acquisition

Ola has acquired Times Internet-backed public transportation app developer Ridlr in an all-stock deal reportedly worth almost $50m.

Apr 4, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here